Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | CCL2 | P13500 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5827695 | 0.74 | LMNA (0.30) | — | |
| SCHEMBL12076336 | 0.69 | P2RX4 (0.32) | BRD4CCL2 | |
| SCHEMBL13236583 | 0.69 | MEN1 (0.50) | BRD4CCL2GAAMAPT | |
| SCHEMBL29418986 | 0.67 | MAPT (0.53) | GAAMAPT | |
| SCHEMBL33554 | 0.67 | — | — | |
| SCHEMBL3767165 | 0.67 | MAPT (0.53) | GAAMAPT | |
| SCHEMBL29398195 | 0.67 | — | — | |
| SCHEMBL29375766 | 0.67 | MAPT (0.53) | GAAMAPT | |
| SCHEMBL4664953 | 0.66 | NOTUM (0.39) | BRD4CCL2 | |
| Water SCHEMBL9798116 | 0.64 | MAPT (0.50) | GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7709263-B2 | Lanthanide complexes preparation and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-05-04 | — | — | US | claimed |
| US-20080044923-A1 | Lanthanide Complexes Preparation and Uses Thereof | UNIVERSITE LOUIS PASTEUR DE STRASBOURG (FR) | 2008-02-21 | — | — | US | claimed |
| US-7838299-B2 | Lanthanide complexes, preparation and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-11-23 | — | — | US | disclosed |
| US-20100216252-A1 | Lanthanide Complexes, Preparation and Uses Thereof | UNIVERSITE LOUIS PASTEUR DE STRASBOURG (FR) | 2010-08-26 | — | — | US | disclosed |
| US-7709263-B2 | Lanthanide complexes preparation and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-05-04 | — | — | US | disclosed |
| US-20080044923-A1 | Lanthanide Complexes Preparation and Uses Thereof | UNIVERSITE LOUIS PASTEUR DE STRASBOURG (FR) | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080044923-A1 | Lanthanide Complexes Preparation and Uses Thereof | NR2E3, GALR3, NR0B2 | BRD4 1041/4885CCL2 564/4885GAA 4589/4885 |
| US-20100216252-A1 | Lanthanide Complexes, Preparation and Uses Thereof | NR2E3, NR0B2, GALR3 | BRD4 878/4885CCL2 686/4885GAA 4590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.